Stroobant V - Search Results

1

Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection.

Uyttenhove C, Arendse B, Stroobant V, Brombacher F, Van Snick J. Uyttenhove C, et al. Among authors: stroobant v. Eur J Immunol. 2004 Dec;34(12):3572-81. doi: 10.1002/eji.200425443. Eur J Immunol. 2004. PMID: 15549728 Free article.

2

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.

Uyttenhove C, Pilotte L, Théate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ. Uyttenhove C, et al. Among authors: stroobant v. Nat Med. 2003 Oct;9(10):1269-74. doi: 10.1038/nm934. Epub 2003 Sep 21. Nat Med. 2003. PMID: 14502282

3

Monitoring of anti-vaccine CD4 T cell frequencies in melanoma patients vaccinated with a MAGE-3 protein.

Zhang Y, Sun Z, Nicolay H, Meyer RG, Renkvist N, Stroobant V, Corthals J, Carrasco J, Eggermont AM, Marchand M, Thielemans K, Wölfel T, Boon T, van der Bruggen P. Zhang Y, et al. Among authors: stroobant v. J Immunol. 2005 Feb 15;174(4):2404-11. doi: 10.4049/jimmunol.174.4.2404. J Immunol. 2005. PMID: 15699177

4

Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis.

Hauer AD, Uyttenhove C, de Vos P, Stroobant V, Renauld JC, van Berkel TJ, van Snick J, Kuiper J. Hauer AD, et al. Among authors: stroobant v. Circulation. 2005 Aug 16;112(7):1054-62. doi: 10.1161/CIRCULATIONAHA.104.533463. Circulation. 2005. PMID: 16103256

5

Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome.

Dalet A, Stroobant V, Vigneron N, Van den Eynde BJ. Dalet A, et al. Among authors: stroobant v. Eur J Immunol. 2011 Jan;41(1):39-46. doi: 10.1002/eji.201040750. Epub 2010 Dec 9. Eur J Immunol. 2011. PMID: 21182075 Free article.

6

Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase.

Pilotte L, Larrieu P, Stroobant V, Colau D, Dolusic E, Frédérick R, De Plaen E, Uyttenhove C, Wouters J, Masereel B, Van den Eynde BJ. Pilotte L, et al. Among authors: stroobant v. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2497-502. doi: 10.1073/pnas.1113873109. Epub 2012 Jan 30. Proc Natl Acad Sci U S A. 2012. PMID: 22308364 Free PMC article.

7

Novel highly specific anti-periostin antibodies uncover the functional importance of the fascilin 1-1 domain and highlight preferential expression of periostin in aggressive breast cancer.

Field S, Uyttenhove C, Stroobant V, Cheou P, Donckers D, Coutelier JP, Simpson PT, Cummings MC, Saunus JM, Reid LE, Kutasovic JR, McNicol AM, Kim BR, Kim JH, Lakhani SR, Neville AM, Van Snick J, Jat PS. Field S, et al. Among authors: stroobant v. Int J Cancer. 2016 Apr 15;138(8):1959-70. doi: 10.1002/ijc.29946. Epub 2015 Dec 21. Int J Cancer. 2016. PMID: 26619948

8

A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein.

Zhang Y, Chaux P, Stroobant V, Eggermont AM, Corthals J, Maillère B, Thielemans K, Marchand M, Boon T, Van Der Bruggen P. Zhang Y, et al. Among authors: stroobant v. J Immunol. 2003 Jul 1;171(1):219-25. doi: 10.4049/jimmunol.171.1.219. J Immunol. 2003. PMID: 12817001

9

Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be improved by acid treatment or fixation of target cells.

Stroobant V, Demotte N, Luiten RM, Leonhardt RM, Cresswell P, Bonehill A, Michaux A, Ma W, Mulder A, Van den Eynde BJ, van der Bruggen P, Vigneron N. Stroobant V, et al. Eur J Immunol. 2012 Jun;42(6):1417-28. doi: 10.1002/eji.201141954. Eur J Immunol. 2012. PMID: 22678898 Free PMC article.

10

Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.

Chaux P, Luiten R, Demotte N, Vantomme V, Stroobant V, Traversari C, Russo V, Schultz E, Cornelis GR, Boon T, van der Bruggen P. Chaux P, et al. Among authors: stroobant v. J Immunol. 1999 Sep 1;163(5):2928-36. J Immunol. 1999. PMID: 10453041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters